Skip to content

Clinical trials

Scleroderma, Diffuse trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Country / region: Mexico Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20191
20222
20233
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Recruiting2
Completed1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Amgen1
AstraZeneca1
Bristol-Myers Squibb1
CSL Behring1
GlaxoSmithKline1
Pfizer1
Prolium Bioscience, Inc1
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Zura Bio Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse11
Scleroderma, Systemic6
Lung Diseases, Interstitial5
Autoimmune Diseases2
Immune System Diseases2
Arthritis, Rheumatoid1
Connective Tissue Diseases1
Fibrosis1
Peripheral Vascular Diseases1
Pulmonary Fibrosis1

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.